The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A framework to assess the cost effectiveness of predictive biomarkers in oncology: Test Incremental Cost Effectiveness Ratio (TICER).
 
Anton Safonov
No Relationships to Disclose
 
Weiwei Shi
No Relationships to Disclose
 
James Platt
No Relationships to Disclose
 
Bilge Aktas
No Relationships to Disclose
 
Tomoko Kurita
No Relationships to Disclose
 
Lajos Pusztai
Honoraria - BioTheranostics; Pfizer
Consulting or Advisory Role - Celgene; Clovis Oncology
Research Funding - Foundation Medicine; Genentech; Merck
 
Christos Hatzis
Employment - Nuvera Biosciences
Stock and Other Ownership Interests - Nuvera Biosciences
Patents, Royalties, Other Intellectual Property - Patent co-inventor. Patent rights co-owned by Nuvera Biosciences and U of Texas MD Anderson Cancer Center (Inst)